India tightens drug quality norms with new pharmacopoeia standards
Implications for vaccine market
The changes have implications for India’s roughly $250 million veterinary vaccine market, as the country continues to contend with outbreaks of zoonotic diseases, including Chandipura virus, West Nile virus, avian influenza, covid-19, fungal zoonoses, hantavirus, Lyme disease, melioidosis, mpox, rabies, Nipah virus and zoonotic tuberculosis.
Post Comment